Sort
21,453 grants matching “tuberculosis”
Targeted Degradation of Mycobacterial PknG for Host Control of Tuberculosis
$254,250Carl F Nathan · Weill Medical Coll Of Cornell Univ · R21 · FY2025 · AI
Interrogating complex mycobacterial population structures using single-cell RNA sequencing
$254,250Kohta Saito · Weill Medical Coll Of Cornell Univ · R21 · FY2024 · AI
Compounds that force Plasmodium falciparum to produce its own inhibitors
$254,250Gang Lin · Weill Medical Coll Of Cornell Univ · R21 · FY2021 · AI
Determination of the mode of action of the antibiotic pyrazinamide
$254,250Alexandre Gouzy · Weill Medical Coll Of Cornell Univ · R21 · FY2024 · AI
Mechanisms of macrophage death co-dependent on M. tuberculosis and IFN-a,b receptor
$254,250Carl F Nathan · Weill Medical Coll Of Cornell Univ · R21 · FY2023 · AI
Novel Inhibitors of Malaria Proteasome
$254,250Gang Lin · Weill Medical Coll Of Cornell Univ · R21 · FY2017 · AI
Macrocyclic proteasome inhibitors for treatment of tuberculosis
$254,250Gang Lin · Weill Medical Coll Of Cornell Univ · R21 · FY2021 · AI
Auto-necroptosis in macrophages
$254,250Adrian T Ting · Icahn School Of Medicine At Mount Sinai · R21 · FY2017 · AI
Role of NadD in Mycobacterium tuberculosis proteostasis
$254,250Benjamin S Gold · Weill Medical Coll Of Cornell Univ · R21 · FY2021 · AI
Turning Mycobacterium tuberculosis appetite for fatty acids against itself
$254,250Sabine Ehrt · Weill Medical Coll Of Cornell Univ · R21 · FY2024 · AI
Host responses to Mycobacterium infection in Zebrafish
$254,197Lalita Ramakrishnan · University Of Cambridge · R01 · FY2023 · AI
Pediatric Infectious Diseases Research Training
$254,189Michael R Wessels · Boston Children'S Hospital · T32 · FY2011 · HD
TB and Innate Immune Regulation of Lung Macrophages
$254,150Ohio State University · R01 · FY2005 · AI
Inter-American Training for Innovations in Emerging Infectious Diseases
$254,122Richard A Oberhelman · Tulane University Of Louisiana · D43 · FY2016 · TW
Pilot Test of an Intervention to Change Syringes Used by Injecting Drug Users
$254,107William A Zule · Research Triangle Institute · R34 · FY2014 · DA
Tuberculosis Control Program provides diagnostic, treatment and prevention services through regional chest clinics and parish health units. All TB services are provided.
$254,082Jim Scioneaux · Louisiana State Office Of Public Health · U52 · FY2016 · PS
Planning for the Metformin for TB/HIV Host-directed Therapy (METHOD) Trial
$253,930Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R34 · FY2016 · AI
TB Diagnosis Based on Promiscuous PE-PGRS Epitopes
$253,813Suman Laal · New York University School Of Medicine · R21 · FY2009 · HL
Marine Fatty Acids as New Antifungal, Antimycobacterial, and Topo-l Agents
$253,811Nestor Manuel Carballeira · University Of Puerto Rico Rio Piedras · SC1 · FY2011 · GM
Research Training in Natural Product Complementary and Integrative Health
$253,764Guido F Pauli · University Of Illinois At Chicago · T32 · FY2024 · AT
Structure of LAM in Relation to Biology and Biosynthesis
$253,750Colorado State University-Fort Collins · R01 · FY2005 · AI
Sterol/Hopanoid Biosynthesis: An Anti-TB Drug Target
$253,750Colorado State University-Fort Collins · R01 · FY2001 · AI
Elucidation of a novel mechanism of macrolide resistance in Mycobacterium abscessus
$253,738Pallavi Ghosh · Wadsworth Center · R21 · FY2019 · AI
Pulmonary Immunopathology Core (PIP)
$253,676Masami Yoshimura · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2025 · GM
Pulmonary Immunopathology Core (PIP)
$253,676Masami Yoshimura · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2024 · GM